Chennai-based Accord Group enters Pharma Business with a Product launch of Onco and Nephro Range
- As a first step, Accord Group is venturing into Indian Market with the introduction of two key therapies Oncology and Nephrology to fill the gap between Quality and Demand
Chennai 12 March 2020: Accord Group, a top notch private sector firm founded
by S. Jagathrakshakan, forays into pharma business with a domain knowledge the
company already has in areas like Healthcare, Hospitality, Information
Technology, Realty, Power Generation, Education, Distilleries, Print and Visual
Media. Headquartered in Chennai, Accord Group now enters the Pharma
Business with a bang as Accord Life Spec Pvt. Ltd (Accord Pharma) with a major
focus on research and development, manufacturing and supply of Sterile and
non-sterile formulation products and API across countries, besides planning to
make a strong impact in Indian pharma
market.
According to Mr. Manish Choube, Global CEO, Accord Life Spec, and Mr. Satessh Singh, Senior
Vice-President, Sales and Marketing, Accord Pharma-India
Business, there are plans to
make the company a global specialty pharmaceutical entity in terms of
innovation of products for patients in the current challenging and competitive
pharmaceutical environment.
This is driven by a strong commitment to quality
compliance and to operating with the highest standards of ethics and
integrity,'' the two top officials said and
added, `we are well-versed with the expectations and trust that
our customers and stakeholders have in us and we work towards creation
of a healthier world.'' They mentioned, “Company will launch various products
in international markets including USA, Europe and various other countries from
next year”.
 |
(L to R) Mr. Satessh Singh, Senior Vice-President, Sales and
Marketing, Accord
Pharma-India Business, Mr Sandeep Anand, Managing Director, Accord Life Spec Pvt. Ltd and Mr. Manish Choube, Global CEO, Accord Life Spec Pvt Ltd. |
As a first step, Accord Group is venturing into
Indian Market with the introduction of two key therapies Oncology and
Nephrology to fill the gap between Quality
and Demand. The products range deals with treatment during blood cancer, breast
cancer, lung cancer, hemodialysis, kidney transplant and renal medicines.
About the formulation products research & development and manufacturing facilities, they said, ‘The world class facility at Oragadam, Chennai, has the required modern equipments for design and development, manufacturing and supply of Parenteral & Oral Solid Dosages Formulations (Oncology and Non-Oncology).''
The two experts further said, ``Our
export-oriented manufacturing facility (EOU) has been built to the strictest
specifications and in accordance with the principles of current Good
Manufacturing Practices as required by the guidelines of the USFDA, UK-MHRA,
PIC/S, TGA-Australia, Health Canada, ANVISA-Brazil, MCC-South Africa, India-DCA
and other regulatory agencies across the globe.''
Accord Life Spec's world class Active Pharmaceutical Ingredients
(APIs) / Biotech Research and Development Centre at Puducherry has a
focus to develop APIs that are competitive and profitable in the long run.
“Accord Life Spec continually seeks new
opportunities to grow its business trajectory through strategic partnerships
with companies seeking support in product
development and manufacturing for oncology and other formulation
products'' they said.
〰〰〰
.jpg)
